Funding Working Capital and Capital Expenditures with Internal Funds or Equity Financing
First written in FY2024-Q3. 10 of 13 entries say "Advanced", first in FY2025-H1. Latest entry: 2026-10-15.
29 other companies' latest entry also says "Advanced".
- 2026-09-09Advancedfinance.yahoo.co.jp
「On 25 August, the company announced the issuance of its 12th Series of Stock Acquisition Rights and a ¥1.51 billion capital raise. On the same day, the share price fell 10.98% from the previous day to ¥73, while trading volume increased 478% from the previous day to 1,811,100 shares.」
The issuance of the 12th Series of Stock Acquisition Rights and the ¥1.51 billion capital raise were specifically reported as part of the company's equity financing policy. - FY2026-H1AdvancedAnnual report
「Funds generated from financing activities during the interim accounting period amounted to ¥509 million, compared with ¥61 million in the same interim period of the previous year. This was mainly attributable to ¥499 million in proceeds from the issuance of shares through the exercise of stock acquisition rights.」
In line with its equity financing policy, the Company raised ¥509 million, mainly through the exercise of stock acquisition rights. - FY2025AdvancedAnnual report
「At an extraordinary meeting of the Board of Directors held on 5 September 2025, the Company resolved to issue the ninth series of stock acquisition rights through a third-party allotment, with an adjustment clause for the exercise price, as well as the 10th and 11th series of stock acquisition rights. Payment in full of the total issue price of these stock acquisition rights was completed on 22 September 2025.」
In addition to raising ¥61 million through the exercise of stock acquisition rights, the Company established an additional funding framework after the end of the fiscal year by issuing the ninth through 11th series of stock acquisition rights, with the proceeds to be allocated to the expansion cohort and other activities for rogocekib. - FY2025-H1AdvancedAnnual report
「Funds generated from financing activities during the interim accounting period amounted to ¥61 million, compared with none in the same interim period of the previous year. This was attributable to ¥61 million in proceeds from the issuance of shares through the exercise of stock acquisition rights.」
In line with its policy of raising funds through internal funds or equity financing, the Company raised ¥61 million through the exercise of stock acquisition rights. - FY2024RestatedAnnual report
「In addition to securing funding for R&D, the Company plans to advance its R&D activities while raising funds as necessary from operating companies and the capital markets through share issuances.」
The policy of securing R&D funding through internal funds, partnership income, share issuances and other sources remains in place. - FY2024-Q3First statedAnnual report
「The Company finances its working capital and capital expenditures through internal funds or equity financing.」
Internal funds and equity financing are cited as sources of funding.